Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
- PMID: 31587352
- PMCID: PMC7781435
- DOI: 10.1111/ejh.13335
Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
Keywords: direct oral anti-coagulant; myeloproliferative; splanchnic vein; thrombosis.
Similar articles
-
Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.Am J Hematol. 2018 Mar;93(3):E61-E64. doi: 10.1002/ajh.24993. Epub 2017 Dec 18. Am J Hematol. 2018. PMID: 29194707 No abstract available.
-
Survival in patients with familial and sporadic myeloproliferative neoplasms.Blood. 2015 Jun 4;125(23):3665-6. doi: 10.1182/blood-2015-04-639039. Blood. 2015. PMID: 26045595 Free PMC article. No abstract available.
-
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients.Br J Haematol. 2020 Dec;191(5):e120-e124. doi: 10.1111/bjh.17084. Epub 2020 Sep 18. Br J Haematol. 2020. PMID: 32945528 No abstract available.
-
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.Curr Hematol Malig Rep. 2018 Jun;13(3):183-190. doi: 10.1007/s11899-018-0446-x. Curr Hematol Malig Rep. 2018. PMID: 29644531 Review.
-
The role of thrombophilia in splanchnic vein thrombosis.Semin Liver Dis. 2008 Aug;28(3):293-301. doi: 10.1055/s-0028-1085097. Epub 2008 Sep 23. Semin Liver Dis. 2008. PMID: 18814082 Review.
Cited by
-
Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.Int J Mol Sci. 2023 Oct 29;24(21):15717. doi: 10.3390/ijms242115717. Int J Mol Sci. 2023. PMID: 37958701 Free PMC article. Review.
-
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific Challenges.J Clin Med. 2025 Feb 25;14(5):1537. doi: 10.3390/jcm14051537. J Clin Med. 2025. PMID: 40095471 Free PMC article. Review.
-
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.Front Oncol. 2021 Feb 16;10:636675. doi: 10.3389/fonc.2020.636675. eCollection 2020. Front Oncol. 2021. PMID: 33665170 Free PMC article. Review.
-
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs.Cancers (Basel). 2022 Dec 20;15(1):11. doi: 10.3390/cancers15010011. Cancers (Basel). 2022. PMID: 36612008 Free PMC article. Review.
-
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.Ann Hematol. 2024 Mar;103(3):737-747. doi: 10.1007/s00277-023-05610-x. Epub 2024 Jan 24. Ann Hematol. 2024. PMID: 38263537 Free PMC article.
References
-
- Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program. 2012;2012:571–581. - PubMed
-
- Ageno W, Riva N, Schulman S, et al. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015;175(9):1474–1480. - PubMed
-
- Lavu S, Szuber N, Mudireddy M, et al. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases. Am J Hematol. 2018;93(3):E61–E64. - PubMed
-
- Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical